Literature DB >> 24821398

Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands.

Suping Bai1, Shihong Li, Jinbin Xu, Xin Peng, Kiran Sai, Wenhua Chu, Zhude Tu, Chenbo Zeng, Robert H Mach.   

Abstract

Two novel classes of compounds targeting the sigma-2 (σ2) receptor were synthesized, and their bioactivities to binding σ1 and σ2 receptors were measured. Four novel triazole carboxamide analogues, 24d, 24e, 24f, and 39c, demonstrated high affinity and selectivity for the σ2 receptor. These data suggest (11)C-labeled versions of these compounds may be potential σ2-selective radiotracers for imaging the proliferative status of solid tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24821398      PMCID: PMC6818095          DOI: 10.1021/jm5001453

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  66 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer.

Authors:  Amalia Azzariti; Nicola A Colabufo; Francesco Berardi; Letizia Porcelli; Mauro Niso; Grazia M Simone; Roberto Perrone; Angelo Paradiso
Journal:  Mol Cancer Ther       Date:  2006-07       Impact factor: 6.261

3.  sigma(2) Receptors regulate changes in sphingolipid levels in breast tumor cells.

Authors:  Keith W Crawford; Andrew Coop; Wayne D Bowen
Journal:  Eur J Pharmacol       Date:  2002-05-17       Impact factor: 4.432

4.  Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1).

Authors:  R Kekuda; P D Prasad; Y J Fei; F H Leibach; V Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  1996-12-13       Impact factor: 3.575

5.  CB-64D and CB-184: ligands with high sigma 2 receptor affinity and subtype selectivity.

Authors:  W D Bowen; C M Bertha; B J Vilner; K C Rice
Journal:  Eur J Pharmacol       Date:  1995-05-24       Impact factor: 4.432

6.  PET Radiotracers for Imaging the Proliferative Status of Solid Tumors.

Authors:  Robert H Mach; Farrokh Dehdashti; Kenneth T Wheeler
Journal:  PET Clin       Date:  2009-01-01

7.  Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.

Authors:  Jinbin Xu; Chenbo Zeng; Wenhua Chu; Fenghui Pan; Justin M Rothfuss; Fanjie Zhang; Zhude Tu; Dong Zhou; Dexing Zeng; Suwanna Vangveravong; Fabian Johnston; Dirk Spitzer; Katherine C Chang; Richard S Hotchkiss; William G Hawkins; Kenneth T Wheeler; Robert H Mach
Journal:  Nat Commun       Date:  2011-07-05       Impact factor: 14.919

8.  The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.

Authors:  John R Hornick; Jinbin Xu; Suwanna Vangveravong; Zhude Tu; Jonathan B Mitchem; Dirk Spitzer; Peter Goedegebuure; Robert H Mach; William G Hawkins
Journal:  Mol Cancer       Date:  2010-11-22       Impact factor: 27.401

9.  Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells.

Authors:  Yifei Zhang; Yixian Huang; Peng Zhang; Xiang Gao; Robert B Gibbs; Song Li
Journal:  Int J Nanomedicine       Date:  2012-08-13

10.  Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma.

Authors:  Hiroyuki Kashiwagi; Jonathan E McDunn; Peter O Simon; Peter S Goedegebuure; Suwanna Vangveravong; Katherine Chang; Richard S Hotchkiss; Robert H Mach; William G Hawkins
Journal:  J Transl Med       Date:  2009-03-26       Impact factor: 5.531

View more
  8 in total

1.  Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.

Authors:  Cédric Lecoutey; Damien Hedou; Thomas Freret; Patrizia Giannoni; Florence Gaven; Marc Since; Valentine Bouet; Céline Ballandonne; Sophie Corvaisier; Aurélie Malzert Fréon; Serge Mignani; Thierry Cresteil; Michel Boulouard; Sylvie Claeysen; Christophe Rochais; Patrick Dallemagne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands.

Authors:  Iredia D Iyamu; Wei Lv; Neha Malik; Rama K Mishra; Gary E Schiltz
Journal:  ChemMedChem       Date:  2019-06-03       Impact factor: 3.466

3.  Identification of the gene that codes for the σ2 receptor.

Authors:  Assaf Alon; Hayden R Schmidt; Michael D Wood; James J Sahn; Stephen F Martin; Andrew C Kruse
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-30       Impact factor: 11.205

4.  MIL-125-based nanocarrier decorated with Palladium complex for targeted drug delivery.

Authors:  Mojtaba Bagherzadeh; Moein Safarkhani; Mahsa Kiani; Fatemeh Radmanesh; Hossein Daneshgar; Amir Mohammad Ghadiri; Fahimeh Taghavimandi; Yousef Fatahi; Nahid Safari-Alighiarloo; Sepideh Ahmadi; Navid Rabiee
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

5.  Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.

Authors:  James J Sahn; Timothy R Hodges; Jessica Z Chan; Stephen F Martin
Journal:  ACS Med Chem Lett       Date:  2017-03-21       Impact factor: 4.345

6.  Design, Synthesis and Biological Evaluation of Novel Triazole N-acylhydrazone Hybrids for Alzheimer's Disease.

Authors:  Matheus de Freitas Silva; Ellen Tardelli Lima; Letizia Pruccoli; Newton G Castro; Marcos Jorge R Guimarães; Fernanda M R da Silva; Nathalia Fonseca Nadur; Luciana Luiz de Azevedo; Arthur Eugen Kümmerle; Isabella Alvim Guedes; Laurent Emmanuel Dardenne; Vanessa Silva Gontijo; Andrea Tarozzi; Claudio Viegas
Journal:  Molecules       Date:  2020-07-10       Impact factor: 4.411

7.  [18F]Fluoro-DCP, a first generation PET radiotracer for monitoring protein sulfenylation in vivo.

Authors:  Kiran Kumar Solingapuram Sai; Xiaofei Chen; Zhe Li; Caigang Zhu; Kirtikar Shukla; Tom E Forshaw; Hanzhi Wu; Stephen A Vance; Buddhika Liyana Pathirannahel; Megan Madonna; Mark W Dewhirst; Allen W Tsang; Leslie B Poole; Nimmi Ramanujam; S Bruce King; Cristina M Furdui
Journal:  Redox Biol       Date:  2021-12-18       Impact factor: 11.799

8.  QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs.

Authors:  Yangxi Yu; Hiep Dong; Youyi Peng; William J Welsh
Journal:  Molecules       Date:  2021-08-30       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.